From: Significance of OCT3/4 and SOX2 antigens expression by leukemic blast cells in adult acute leukemia
Parameter | Univariable | Multivariable | ||||
---|---|---|---|---|---|---|
P | HR | 95% CI | P value | HR | 95% CI | |
Age (years) | 0.785 | 1.003 | 0.984–1.022 | |||
Gender | 0.784 | 1.117 | 0.506–2.464 | |||
WBCs × 109/L | 0.827 | 1.001 | 0.955–1.006 | |||
Hemoglobin g/dl | 0.657 | 0.952 | 0.767–1.182 | |||
Platelets count × 109/L | 0.367 | 0.996 | 0.989–1.004 | |||
Bone marrow blast % | 0.218 | 1.003 | 0.989–1.008 | |||
Risk stratification | ||||||
Favorable | R | 1 | – | R | 1 | – |
Intermediate | 0.027 | 4.535 | 1.190–17.287 | 0.118 | 3.200 | 0.744–13.760 |
Poor | < 0.001 | 24.463 | 6.283–95.244 | 0.187 | 4.425 | 0.982–40.220 |
Response (non-CR vs CR) | < 0.001 | 10.294 | 4.107–25.802 | 0.052 | 6.078 | 0.982–37.634 |
Relapse (relapsed vs non-relapsed) | 0.471 | 1.494 | 0.502–4.450 | |||
SOX2 expression (%) | < 0.001 | 1.034 | 1.019–1.050 | 0.001 | 1.033 | 1.014–1.054 |
OCT3/4 expression (%) | 0.001 | 1.179 | 1.027–1.353 | 0.045 | 1.163 | 1.021–1.339 |